⚡ Asset Showdown Engine

ABBV vs JNJ

Head-to-head financial comparison for AbbVie Inc (ABBV) and Johnson & Johnson (JNJ).

🏆 Showdown Verdict

ABBV leads JNJ in 9 of 17 key financial metrics.

ABBV: 9 wins · JNJ: 8 wins
NEW YORK STOCK EXCHANGE, INC. · Biotechnology

ABBV

AbbVie Inc
$284.66
-1.49%
After hours
52-Week Range 93.3% of High
Low: $190.75 High: $291.40
💼
Profitability Winner Higher Operating & Net Margins
💰
Income Winner Higher Dividend Yield
🚀
Performance Winner Higher Historical Returns
NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals

JNJ

Johnson & Johnson
$284.66
-1.49%
🌆 After hours
🌆 After-Hours: $285.00 (+0.07%)
52-Week Range 93.3% of High
Low: $190.75 High: $291.40
💼
Profitability Winner Higher Operating & Net Margins
💰
Income Winner Higher Dividend Yield
🚀
Performance Winner Higher Historical Returns
NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals

JNJ

Johnson & Johnson
$257.63
-0.69%
🌆 After hours
🌆 After-Hours: $257.78 (0.00%)
52-Week Range 75.7% of High
Low: $184.66 High: $281.07
🏷️
Valuation Winner Lower P/E & Multiples
🏛️
Scale Leader Larger Market Cap

Normalized % Return Comparison

Both assets indexed to 0.0% at the period start: ((Price_t - Price_0) / Price_0 * 100)

Benchmark:
ABBV (AbbVie Inc) +29.24%
JNJ (Johnson & Johnson) +37.14%
JNJ leads by +7.90%
-20.5%-1.1%+18.3%+37.8%+57.2% Oct '25Jan '26Apr '26Jul '26Oct '26

Metric-by-Metric Breakdown

Direct quantitative comparison across valuation, margins, growth, and returns.

Financial Metric ABBV JNJ Showdown Advantage
Valuation & Multiples
Price Current market price per share / unit $284.66 $257.63 —
Market Capitalization Total aggregate market value of equity $508.71B $617.92B 👑 JNJ Larger
P/E Ratio (Trailing TTM) Price-to-earnings multiple (lower positive is cheaper) 80.96x 38.86x 👑 JNJ Cheaper
Forward P/E Price-to-projected next year earnings multiple 16.93x 21.98x 👑 ABBV Lower
PEG Ratio P/E divided by earnings growth rate (<1.0 considered undervalued) 3.49 3.44 👑 JNJ Lower
Price to Sales (P/S) Price relative to trailing revenue 7.93x 6.30x 👑 JNJ Lower
Price to Book (P/B) Stock price relative to book equity per share 261.01x 7.32x 👑 JNJ Lower
Profitability & Margins
Gross Profit Margin Gross revenue retained after cost of goods sold 72.79% 67.69% 👑 ABBV Higher
Operating Margin Operating income generated per dollar of revenue 26.20% 17.86% 👑 ABBV Higher
Net Profit Margin Net bottom-line profit generated per dollar of revenue 9.80% 16.20% 👑 JNJ Higher
Return on Equity (ROE) Net income earned per dollar of shareholders' equity 95.59% 25.74% 👑 ABBV Higher
Historical Performance & Growth
Revenue Growth (YoY) Year-over-year top-line revenue expansion rate +10.16% +5.86% 👑 ABBV Higher
1-Month % Return Historical total price return over the past 30 days +9.09% -3.62% 👑 ABBV Higher
6-Month % Return Historical total price return over the past 180 days +36.92% +7.92% 👑 ABBV Higher
1-Year % Return Historical total price return over the past 52 weeks +29.24% +37.14% 👑 JNJ Higher
5-Year % Return Historical total price return over 5 years +211.48% +80.93% 👑 ABBV Higher
Dividends & Risk
Dividend Yield Annual dividend distributions relative to current price 4.47% 3.12% 👑 ABBV Higher
Beta (Volatility vs S&P 500) Market sensitivity (1.0 = equal to market, <1.0 = lower volatility) 0.20 0.20 —
52-Week High & Low Extreme trading boundaries over trailing year $190.75 – $291.40 $184.66 – $281.07 —